Text Size

Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: A pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies

Leonardi A., Messmer E.M., Labetoulle M., Amrane M., Garrigue J.-S., Ismail D., Sainz-De-La-Maza M., Figueiredo F.C., Baudouin C.

  • 2019
  • British Journal of Ophthalmology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology


  • Categories

    Clinical development

  • Affiliations

    Department of Neuroscience, Ophthalmology Unit, University of Padua, Giustiniani 2, Padua, 35128, Italy; Department of Ophthalmology, Ludwig-Maximilian University of Munich, Munich, Germany; Department of Ophthalmology, Bicêtre Hospital, APHP, Paris-Sud University, Le Kremlin Bicêtre, France; Santen SAS, Evry, France; Institute Clinic of Ophthalmology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Department of Ophthalmology, Royal Victoria Infirmary, Newcastle University, Newcastle Upon Tyne, United Kingdom; Quinze-Vingts National Ophthalmology Hospital, Paris, France; Vision Institute, INSERM UMRS968, CNRS UMR7210, UPMC University, Paris, France; University of Versailles Saint-Quentin en Yvelines, Versailles, France

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P,  Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022